| scholarly article | Q13442814 |
| P50 | author | Bengt Jeppsson | Q79419970 |
| P2093 | author name string | Göran Molin | |
| Siv Ahrné | |||
| Anna Berggren | |||
| Caroline Karlsson | |||
| Gunilla Nordin Fredrikson | |||
| Ingrid Palmquist | |||
| P433 | issue | 1 | |
| P921 | main subject | bacterial diversity | Q129941212 |
| probiotics | Q1816730 | ||
| P304 | page(s) | 228-233 | |
| P577 | publication date | 2009-06-18 | |
| P1433 | published in | Atherosclerosis | Q4813570 |
| P1476 | title | Probiotic therapy to men with incipient arteriosclerosis initiates increased bacterial diversity in colon: a randomized controlled trial. | |
| P478 | volume | 208 |
| Q38185183 | 'The way to a man's heart is through his gut microbiota'--dietary pro- and prebiotics for the management of cardiovascular risk. |
| Q36880959 | A low dose of an organophosphate insecticide causes dysbiosis and sex-dependent responses in the intestinal microbiota of the Japanese quail (Coturnix japonica). |
| Q35000008 | Alteration of the intestinal microbiome: fecal microbiota transplant and probiotics for Clostridium difficile and beyond |
| Q90376824 | An examination of data from the American Gut Project reveals that the dominance of the genus Bifidobacterium is associated with the diversity and robustness of the gut microbiota |
| Q36596797 | Association between Bacterial Infection and Peripheral Vascular Disease: A Review |
| Q90601591 | Branched Short-Chain Fatty Acid Isovaleric Acid Causes Colonic Smooth Muscle Relaxation via cAMP/PKA Pathway |
| Q54372904 | Characterization of fecal microbial communities in patients with liver cirrhosis. |
| Q55409994 | Cross-Talk between Gut Microbiota and Heart via the Routes of Metabolite and Immunity. |
| Q60919912 | Dietary Composition and Cardiovascular Risk: A Mediator or a Bystander? |
| Q34521346 | Diverse effects of oats on cholesterol metabolism in C57BL/6 mice correlate with expression of hepatic bile acid-producing enzymes |
| Q37731242 | Effects of Dietary Yogurt on the Healthy Human Gastrointestinal (GI) Microbiome |
| Q47383811 | Effects on weight gain and gut microbiota in rats given bacterial supplements and a high-energy-dense diet from fetal life through to 6 months of age. |
| Q64279320 | Endocrine organs of cardiovascular diseases: Gut microbiota |
| Q22001357 | Fermented foods, microbiota, and mental health: ancient practice meets nutritional psychiatry |
| Q36329055 | Gut Microbiota in Cardiovascular Health and Disease |
| Q36271749 | Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke |
| Q34602100 | Health effects of olive oil polyphenols: recent advances and possibilities for the use of health claims |
| Q59822020 | High fat diet induced atherosclerosis is accompanied with low colonic bacterial diversity and altered abundances that correlates with plaque size, plasma A-FABP and cholesterol: a pilot study of high fat diet and its intervention with Lactobacillus r |
| Q35020376 | Immunological alteration and changes of gut microbiota after dextran sulfate sodium (DSS) administration in mice |
| Q91973303 | Immunomodulatory effect of Syphacia obvelata in treatment of experimental DSS-induced colitis in mouse model |
| Q21198786 | Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: Part II - contemporary contextual research |
| Q38335183 | Intestinal mucosal tolerance and impact of gut microbiota to mucosal tolerance |
| Q83704795 | Lactobacillus plantarum 299v does not reduce enteric bacteria or bacterial translocation in patients undergoing colon resection |
| Q39044349 | Mechanisms responsible for the hypocholesterolaemic effect of regular consumption of probiotics |
| Q37125327 | Oral administration of live exopolysaccharide-producing Pediococcus parvulus, but not purified exopolysaccharide, suppressed Enterobacteriaceae without affecting bacterial diversity in ceca of mice. |
| Q37217947 | Probiotic mixture VSL#3 reduce high fat diet induced vascular inflammation and atherosclerosis in ApoE(-/-) mice |
| Q39025406 | Role of gut microbiota in atherosclerosis |
| Q26801649 | Role of gut microbiota in the modulation of atherosclerosis-associated immune response |
| Q35961347 | The Effect of Probiotic Treatment on Patients Infected with the H7N9 Influenza Virus |
| Q89943833 | The Gut Microbiota and Its Implication in the Development of Atherosclerosis and Related Cardiovascular Diseases |
| Q65002701 | The Role of the Microbiota in the Diabetic Peripheral Artery Disease. |
| Q47312781 | The microbiota of the gut in preschool children with normal and excessive body weight. |
| Q39744092 | The pioneer gut microbiota in human neonates vaginally born at term-a pilot study |
| Q34144918 | Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review |
Search more.